Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.195 USD | -1.30% | -4.71% | -40.17% |
04-30 | Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating | MT |
04-26 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.17% | 571M | |
+20.30% | 84.31B | |
-29.57% | 69.9B | |
+9.65% | 29.06B | |
-8.98% | 17.38B | |
+2.14% | 17.01B | |
-0.10% | 15.35B | |
+7.34% | 12.91B | |
+68.44% | 12.47B | |
+6.43% | 12.26B |
- Stock Market
- Equities
- ACCD Stock
- News Accolade, Inc.
- Raymond James Adjusts Price Target on Accolade to $12 From $15, Keeps Outperform Rating